Literature DB >> 27549399

New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.

Anders Helander1,2, Matilda Bäckberg3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27549399     DOI: 10.1080/15563650.2016.1217003

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


× No keyword cloud information.
  5 in total

1.  New drug controls and reduced hospital presentations due to novel psychoactive substances in Edinburgh.

Authors:  Janice Pettie; Allan Burt; Duleeka W Knipe; Hazel Torrance; Margaret Dow; Karen Osinski; Robert Greig; Diletta Sabatini; Kate Easterford; James Dear; Michael Eddleston
Journal:  Br J Clin Pharmacol       Date:  2018-07-20       Impact factor: 4.335

Review 2.  Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.

Authors:  Amanda L A Mohr; Barry K Logan; Melissa F Fogarty; Alex J Krotulski; Donna M Papsun; Sherri L Kacinko; Marilyn A Huestis; Jeri D Ropero-Miller
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

3.  The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users.

Authors:  Barak Shapira; Paola Rosca; Ronny Berkovitz; Igor Gorjaltsan; Yehuda Neumark
Journal:  PeerJ       Date:  2020-07-17       Impact factor: 2.984

4.  Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project.

Authors:  Anders Helander; Matilda Bäckberg; Olof Beck
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

5.  Acute recreational drug toxicity: Comparison of self-reports and results of immunoassay and additional analytical methods in a multicenter European case series.

Authors:  Evangelia Liakoni; Christopher Yates; Alison M Dines; Paul I Dargan; Fridtjof Heyerdahl; Knut Erik Hovda; David M Wood; Florian Eyer; Matthias E Liechti
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.